The application is for the treatment of mild to moderate Covid in adults who are at risk of severe and / or hospitalization.
If authorized – which can take a few weeks – the medicine will be the first pill to treat the disease. All other FDA-authorized treatments require intravenous injection.
On October 1, Merck announced that its drugs had reduced hospitalization and deaths. in people with early coronavirus infection.
The FDA has yet to review the company’s data on the safety and efficacy of the drug, molnupiravir, before making a decision.
Three antibody drugs authorized by the agency have been shown to be very effective in reducing deaths from Covid-19, but they are expensive, difficult to produce, and require specialized equipment and healthcare professionals to apply.
Since the onset of the pandemic, experts have highlighted the need for pill treatment. The goal is to have something similar to oseltamivir, a flu medicine used for 20 years that reduces the disease in a day or two and relieves the severity of symptoms such as fever, cough and stuffy nose.
Also on Monday (11), the British pharmaceutical company AstraZeneca announced that its cocktail of experimental drugs against Covid-19 has been shown to be effective in reducing severe cases and deaths in out-of-hospital patients.
The results have not yet been evaluated by other scientists or published in a scientific journal.
The medicine, called AZD7442, reduced by 50% the risk of developing the severe form of the disease and death in symptomatic patients, the drug maker said. The study followed about 900 people.
Watch VIDEO about Covid-19 vaccines: